Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F16%3A43914800" target="_blank" >RIV/00023752:_____/16:43914800 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/16:43910988
Result on the web
<a href="http://journals.lww.com/behaviouralpharm/Abstract/2016/06000/Sex_differences_and_serotonergic_mechanisms_in_the.1.aspx" target="_blank" >http://journals.lww.com/behaviouralpharm/Abstract/2016/06000/Sex_differences_and_serotonergic_mechanisms_in_the.1.aspx</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/FBP.0000000000000198" target="_blank" >10.1097/FBP.0000000000000198</a>
Alternative languages
Result language
angličtina
Original language name
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Original language description
Psilocybin has recently attracted a great deal of attention as a clinical research and therapeutic tool. The aim of this paper is to bridge two major knowledge gaps regarding its behavioural pharmacology i.e. sex differences and the underlying receptor mechanisms. We used psilocin (0.25, 1 and 4 mg/kg), an active metabolite of psilocybin, in two behavioural paradigms - the open field test and the test of prepulse inhibition (PPI) of acoustic startle reaction. Sex differences were evaluated with respect to the phase of the female cycle. The contribution of serotonin receptors in the behavioural action was tested in male rats with selective serotonin receptor antagonists: 5-HT1A receptor antagonist (WAY100635 1 mg/kg), 5-HT2A receptor antagonist (MDL100907 0.5 mg/kg), 5-HT2B receptor antagonist (SB215505 1 mg/kg) and 5-HT2C receptor antagonist (SB242084 1 mg/kg). Psilocin induced dose dependent inhibition of locomotion and suppression of normal behaviour of rats (behavioural serotonin syndrome, impaired PPI). The effects were most pronounced in male rats, female rats were affected by psilocin treatment to a lesser degree. The inhibition of locomotion was normalized by 5-HT1A and 5-HT2B/C antagonists; however PPI was not affected significantly by antagonists used. Our findings highlight an important issue of sex specific reactions to psilocin and that apart from 5-HT2A mediated effects 5-HT1A and 5-HT2C/B receptors also play an important role. These findings have further implications for recent clinical trials.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FL - Psychiatry, sexology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Behavioural Pharmacology
ISSN
0955-8810
e-ISSN
—
Volume of the periodical
27
Issue of the periodical within the volume
4
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
309-320
UT code for WoS article
000375627500001
EID of the result in the Scopus database
2-s2.0-84965046020